The NIH and the National Cancer Institute awarded Epic Sciences a Small Business Innovation Research grant to develop a test to detect and specify circulating tumor cells in lung cancer patients. Epic previously won a Phase I grant. The grants total $1.2 million.
Epic Sciences wins federal grant to develop lung cancer test
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan